XENE
Xenon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$35.08
+4.75%2
Insider buys (3m)
3
Insider sells (3m)
$614.8K
Net value (3m)
-47.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 16, 2026 | Kelly Thomas Patrick · officer: Chief Financial Officer | M-Exempt | 7,500 | $0.00 |
| Oct 1, 2026 | Kelly Thomas Patrick · officer: Chief Financial Officer | Purchase | 15,000 | $37 |
| Oct 1, 2026 | MORTIMER IAN · director, officer: PRESIDENT & CEO | Purchase | 30,000 | $37 |
| Sep 3, 2026 | Svoronos Dawn · director | M-Exempt | 5,144 | $8.15 |
| Aug 31, 2026 | KENNEY CHRISTOPHER JOHN · officer: Chief Medical Officer | Sale | 700 | $61 |
| Aug 31, 2026 | KENNEY CHRISTOPHER JOHN · officer: Chief Medical Officer | Sale | 6,368 | $60 |
| Aug 13, 2026 | GANNON STEVEN · director | Sale | 10,000 | $64 |
| Jun 8, 2026 | Cannon Gillian · director | Sale | 1,190 | $53 |
| Jun 8, 2026 | PATOU GARY · director | Sale | 1,322 | $53 |
| Jun 3, 2026 | Gover Justin D. · director | A-Award | 10,507 | $53 |
| Jun 3, 2026 | GANNON STEVEN · director | A-Award | 10,507 | $53 |
| Jun 3, 2026 | Svoronos Dawn · director | F-InKind | 1,416 | $53 |
| Jun 3, 2026 | Gover Justin D. · director | M-Exempt | 2,645 | $0.00 |
| Jun 3, 2026 | GAROFALO ELIZABETH A. · director | M-Exempt | 2,645 | $0.00 |
| Jun 3, 2026 | Cannon Gillian · director | A-Award | 10,507 | $53 |
| Jun 3, 2026 | GANNON STEVEN · director | M-Exempt | 2,645 | $0.00 |
| Jun 3, 2026 | GAROFALO ELIZABETH A. · director | A-Award | 1,593 | $0.00 |
| Jun 3, 2026 | Cannon Gillian · director | M-Exempt | 2,645 | $0.00 |
| Jun 3, 2026 | Machado Patrick · director | A-Award | 10,507 | $53 |
| Jun 3, 2026 | GANNON STEVEN · director | A-Award | 1,593 | $0.00 |
| Jun 3, 2026 | PATOU GARY · director | A-Award | 10,507 | $53 |
| Jun 3, 2026 | GANNON STEVEN · director | F-InKind | 1,416 | $53 |
| Jun 3, 2026 | Machado Patrick · director | A-Award | 1,593 | $0.00 |
| Jun 3, 2026 | PATOU GARY · director | A-Award | 1,593 | $0.00 |
| Jun 3, 2026 | Machado Patrick · director | M-Exempt | 2,645 | $0.00 |
| Jun 3, 2026 | GAROFALO ELIZABETH A. · director | A-Award | 10,507 | $53 |
| Jun 3, 2026 | Svoronos Dawn · director | A-Award | 1,593 | $0.00 |
| Jun 3, 2026 | Svoronos Dawn · director | M-Exempt | 2,645 | $0.00 |
| Jun 3, 2026 | PATOU GARY · director | M-Exempt | 2,645 | $0.00 |
| Jun 3, 2026 | Svoronos Dawn · director | A-Award | 10,507 | $53 |
Institutional positioning
13F filings over the trailing two quarters
New 130Increased 249Reduced 154Sold out 26
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 10,818,491 | May 15, 2026 |
| FMR LLC | Reduced | 9,647,998 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 7,522,482 | Aug 7, 2026 |
| Avoro Capital Advisors LLC | Unchanged | 5,777,777 | Aug 14, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 5,777,777 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5,640,118 | May 13, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4,829,641 | May 15, 2026 |
| Polar Capital Holdings Plc | Increased | 4,570,556 | Aug 14, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Reduced | 4,491,653 | May 15, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Reduced | 4,418,557 | Aug 14, 2026 |
| POLAR CAPITAL HOLDINGS PLC | Increased | 4,405,312 | May 15, 2026 |
| Jupiter Topco LLC | New Position | 4,186,519 | Aug 14, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 4,175,982 | May 18, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 3,248,219 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 2,886,390 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 16, 2026